These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19338024)

  • 21. Behavioral therapy, sertraline, or both in childhood anxiety.
    Hoffman L
    N Engl J Med; 2009 Jun; 360(23):2476; author reply 2477. PubMed ID: 19504760
    [No Abstract]   [Full Text] [Related]  

  • 22. Psychosocial and pharmacological treatment for pediatric anxiety disorders.
    Fisher PH; Tobkes JL; Kotcher L; Masia-Warner C
    Expert Rev Neurother; 2006 Nov; 6(11):1707-19. PubMed ID: 17144784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Guidelines of the Brazilian Medical Association for the treatment of social anxiety disorder].
    Levitan MN; Chagas MH; Crippa JA; Manfro GG; Hetem LA; Andrada NC; Salum GA; Isolan L; Ferrari MC; Nardi AE;
    Braz J Psychiatry; 2011 Sep; 33(3):292-302. PubMed ID: 21971784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of CBT with fluoxetine works better for obsessive-compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP
    Asian J Psychiatr; 2012 Mar; 5(1):113. PubMed ID: 26878959
    [No Abstract]   [Full Text] [Related]  

  • 25. Pediatric anxiety disorders: management in primary care.
    Sakolsky D; Birmaher B
    Curr Opin Pediatr; 2008 Oct; 20(5):538-43. PubMed ID: 18781116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral therapy, sertraline, or both in childhood anxiety.
    Rifkin A; Braga RJ
    N Engl J Med; 2009 Jun; 360(23):2475-6; author reply 2477. PubMed ID: 19494227
    [No Abstract]   [Full Text] [Related]  

  • 27. Neural Responsiveness to Reward as an Index of Depressive Symptom Change Following Cognitive-Behavioral Therapy and SSRI Treatment.
    Burkhouse KL; Gorka SM; Klumpp H; Kennedy AE; Karich S; Francis J; Ajilore O; Craske MG; Langenecker SA; Shankman SA; Hajcak G; Phan KL
    J Clin Psychiatry; 2018 Jun; 79(4):. PubMed ID: 29894598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral therapy, sertraline, or both in childhood anxiety.
    Bremner JD; Vaccarino V
    N Engl J Med; 2009 Jun; 360(23):2476; author reply 2477. PubMed ID: 19504764
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical practice guidelines for depression in young people: are the treatment recommendations outdated?
    Chan RT; Rey JM; Hazell PL
    Med J Aust; 2002 Oct; 177(8):448-51. PubMed ID: 12381257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Six decades of preventing and treating childhood anxiety disorders: a systematic review and meta-analysis to inform policy and practice.
    Schwartz C; Barican JL; Yung D; Zheng Y; Waddell C
    Evid Based Ment Health; 2019 Aug; 22(3):103-110. PubMed ID: 31315926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents.
    Garland EJ; Baerg EA
    J Child Adolesc Psychopharmacol; 2001; 11(2):181-6. PubMed ID: 11436958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric anxiety--underrecognized and undertreated.
    Emslie GJ
    N Engl J Med; 2008 Dec; 359(26):2835-6. PubMed ID: 19109579
    [No Abstract]   [Full Text] [Related]  

  • 33. Psychopharmacologic treatment of children and adolescents with anxiety disorders.
    Strawn JR; Sakolsky DJ; Rynn MA
    Child Adolesc Psychiatr Clin N Am; 2012 Jul; 21(3):527-39. PubMed ID: 22800992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Introduction. New treatments for anxiety disorders: clinical approaches for successful outcomes.
    Sheehan DV
    J Clin Psychiatry; 1999; 60 Suppl 18():3. PubMed ID: 10487249
    [No Abstract]   [Full Text] [Related]  

  • 36. Prognostic subgroups for remission and response in the Coordinated Anxiety Learning and Management (CALM) trial.
    Kelly JM; Jakubovski E; Bloch MH
    J Clin Psychiatry; 2015 Mar; 76(3):267-78. PubMed ID: 25562579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Guidelines for care of young people with anxiety and depression should be revised].
    Högberg G; Werner B; Cederblad M; Wrangsjö B
    Lakartidningen; 2010 Nov 10-16; 107(45):2823-4; discussion 2825. PubMed ID: 21179869
    [No Abstract]   [Full Text] [Related]  

  • 38. The Influence of Pharmacodynamic Genes on Fluoxetine Response in Pediatric Anxiety and Depressive Disorders.
    Troy TF; Poweleit EA; Strawn JR; Martin LJ; Ramsey LB
    J Child Adolesc Psychopharmacol; 2020 May; 30(4):276-277. PubMed ID: 32073889
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of children with antidepressants: focus on selective serotonin reuptake inhibitors.
    Emslie GJ; Weinberg WA; Mayes TL
    Depress Anxiety; 1998; 8 Suppl 1():13-7. PubMed ID: 9809209
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of selective serotonin reuptake inhibitors in childhood depression.
    Wohlfarth T; Lekkerkerker F; van Zwieten B
    Lancet; 2004 Aug 21-27; 364(9435):659-60; author reply 661. PubMed ID: 15325820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.